Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
CytoDyn Inc CYDY
(Total Views: 1648)
Posted On: 05/03/2020 8:23:22 AM
Post# of 153886
Avatar
Posted By: Sunny3999
Re: Riztheinvestor #31629
Quote:
How much you think a buyout would be?


My first answer is "Priceless" but if you would like me to add figures!

Here would be my humble opinion:

Cytodyn has a patent security of at least 12 years!

After 12 years still no one can fill a generica application, due to the ingredients to produce a copy of Vyrologics (Leronlimab-Pro140)!

I assume at least a 10% market share due to 0 SAE for 7 years always!!

Evaluating HIV:
The global HIV drugs market size was valued at USD 25,314.0 Million in 2018 and is projected to reach USD 40,675.0 Million by the end of 2026, exhibiting a CAGR of 6,1% in the forecast period of 2019-2026!

https://www.fortunebusinessinsights.com/indus...ket-101115

average $ 3,3 bn/p.a. = $ 23,1 bn alone HIV !!

Cancer 22 various - Oncology Drugs Market Overview:
The global oncology/cancer drugs market was valued at $97,401 million in 2017, and is estimated to reach at $176,509 million by 2025, registering a CAGR of 7.6% from 2018 to 2025.

https://www.alliedmarketresearch.com/oncology...ugs-market
average p.a. $13,8 bn = 96,6 bn in Cancer treatments

GHvD global market:
The global graft versus host disease market is expected to grow at a CAGR of 7% from 2016-2021 and CAGR of 3% from 2019-2029. The market is exp[url][/url]ected to grow at a CAGR of 6% from 2016 to 2027. The market is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in 2026.

https://www.visiongain.com/report/global-graf...2019-2029/

average p.a. $0,05 bn = 0,35 bn in GHvD treatments

Additional not specified implications of Vyrologics:

Opinion appr. 10 bn or more!

Last but not least a mutating COVID-19 regards medical updates where might no vaccine will be found!

This could be between 5-10 mn citizen per year to use Leronlimab:

This could add 5-10 bn p.a. = 35-70 bn

Sum of implications for a buyout for 7 years turnover:

appr. 165,05 - 200 bn for a buyout just for a 7 years period of turnover!

Big Pharma would still have the rest of 5+ years to earn money with bigger turnover as CAGR grows YoY!

Hope my assumptions are somehow not out of the blue....and still it is low and
might i have forgotten some of the list of all diseases written by a poster here!

Just IMO



















(4)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site